Picture this scenario: A 54-year-old kidney transplant recipient has been stable on cyclosporine for three years. Feeling fatigued and occasionally depressed, she visits a naturopath who recommends St. John's Wort—a natural herbal supplement marketed as safe for mood support. Within weeks, her transplant rejection labs show alarming changes. Her cyclosporine levels have plummeted. The herbal supplement she believed was harmless has triggered a cascade of immunological changes that now threaten her transplanted organ. This scenario, while specific, reflects a real and serious interaction risk documented in FDA drug labeling and clinical practice.
St. John's Wort and cyclosporine represent one of the most clinically significant interactions between an over-the-counter herbal product and a critical immunosuppressant medication. Understanding this interaction is essential for transplant patients, healthcare providers, and anyone considering herbal supplementation while on prescription medications.
St. John's Wort (Hypericum perforatum) is a flowering plant long used in traditional medicine. Today, it is widely available as an over-the-counter dietary supplement in capsules, teas, and tinctures. Many people take St. John's Wort for:
Because it is sold as a dietary supplement rather than a pharmaceutical drug, many consumers assume it is entirely safe and risk-free. However, FDA drug labeling for numerous medications—including immunosuppressants like cyclosporine—specifically warns against St. John's Wort co-administration due to serious interaction potential.
Cyclosporine is a potent immunosuppressant medication used to prevent organ and tissue rejection after transplantation and to treat certain autoimmune conditions. FDA drug labeling indicates cyclosporine is prescribed for:
For transplant patients especially, maintaining stable cyclosporine levels is a matter of life and death. Even modest reductions in blood concentration can trigger acute rejection episodes—a medical emergency that may result in permanent organ damage or loss of the transplanted organ.
The St. John's Wort–cyclosporine interaction operates through a well-established pharmacological mechanism: enzyme induction.
Cyclosporine is metabolized (broken down) in the liver primarily by cytochrome P450 enzyme 3A4 (CYP3A4). St. John's Wort contains active compounds—particularly hyperforin and hypericin—that induce (activate and upregulate) CYP3A4 expression. When these enzymes are more active, they metabolize cyclosporine much faster than normal, causing:
Clinical reports documented in transplant literature describe cyclosporine levels dropping by 50% or more when St. John's Wort is introduced. This is not a minor interaction—it is a potential organ-threatening event.
The U.S. FDA label for cyclosporine explicitly warns against concurrent use with St. John's Wort. FDA drug labeling states that St. John's Wort may reduce cyclosporine concentrations and efficacy. This warning reflects documented adverse event reports tracked through the FDA Adverse Event Reporting System (FAERS), where cases of transplant rejection associated with St. John's Wort use have been reported.
The interaction is so well-established that major medical organizations—including transplant societies and pharmacy associations—have issued clear guidance: St. John's Wort is contraindicated in patients taking cyclosporine.
Not all drug interactions are equally serious. The St. John's Wort–cyclosporine interaction is particularly concerning because:
Transplant patients taking both St. John's Wort and cyclosporine may experience:
Any transplant patient with unexplained graft dysfunction should be asked directly about herbal supplement use.
If you take cyclosporine: Do not use St. John's Wort without explicit approval from your transplant physician or pharmacist. Always disclose all supplements—including herbal products, vitamins, and over-the-counter remedies—to your healthcare team. When in doubt, ask your pharmacist before starting any new product.
If you are considering St. John's Wort for mood: Discuss alternative options with your physician. There are many evidence-based treatments for depression and anxiety that do not interact with cyclosporine.
For healthcare providers: Screen transplant and immunosuppressed patients for herbal supplement use at every visit. Provide clear, written guidance about which supplements are contraindicated.
Patients struggling with mood symptoms while on cyclosporine have effective, non-interacting options:
The interaction between St. John's Wort and cyclosporine is a clear example of why herbal supplements cannot be assumed safe simply because they are natural or available without a prescription. FDA drug labeling, clinical evidence, and transplant medicine practice all agree: this combination poses a serious, organ-threatening risk.
If you or a loved one takes cyclosporine, avoid St. John's Wort entirely. If you are considering any herbal supplement, always verify its safety profile with your pharmacist or physician first. Your transplanted organ—and your life—depend on maintaining adequate immunosuppression.
To check for interactions between any medications or supplements you are considering, visit checkdruginteractions.com—the most comprehensive drug interaction checker on the internet, powered by over 250,000 FDA-labeled drug records.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Methotrexate and ibuprofen have a major FDA-documented interaction. Learn mechanism, monitoring, and safe management strategies for healt...
Tacrolimus and fluconazole interaction explained. Learn severity, risks, and what FDA labels say about combining these drugs.
Is it safe to take methimazole and warfarin together? Learn about this drug interaction from FDA data and pharmacology.